+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Guide RNA"

Synthetic DNA - Global Strategic Business Report - Product Thumbnail Image

Synthetic DNA - Global Strategic Business Report

  • Report
  • August 2026
  • 181 Pages
  • Global
From
Oligonucleotide Synthesis - Global Strategic Business Report - Product Thumbnail Image

Oligonucleotide Synthesis - Global Strategic Business Report

  • Report
  • August 2026
  • 383 Pages
  • Global
From
From
From
From
From
DNA Synthesizer Market - Forecast from 2026 to 2031 - Product Thumbnail Image

DNA Synthesizer Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 128 Pages
  • Global
From
RNA Analysis Market - Forecast from 2026 to 2031 - Product Thumbnail Image

RNA Analysis Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 140 Pages
  • Global
From
From
From
From
From
From
From
From
From
Genome Editing Technologies Market Report 2024-2034 - Product Thumbnail Image

Genome Editing Technologies Market Report 2024-2034

  • Report
  • May 2024
  • 311 Pages
  • Global
From
Loading Indicator

The Guide RNA (gRNA) market is a subset of the genomics industry that focuses on the development and production of gRNA molecules. gRNA molecules are used in a variety of applications, including gene editing, gene regulation, and gene expression. gRNA molecules are composed of a guide sequence, which is complementary to a specific target sequence in the genome, and a scaffold sequence, which provides stability and specificity to the gRNA molecule. The gRNA market is driven by the increasing demand for gene editing and gene regulation technologies, as well as the growing need for more efficient and cost-effective gene expression tools. Additionally, the development of new gRNA technologies, such as CRISPR-Cas9, has further increased the demand for gRNA molecules. Some of the major companies in the gRNA market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, New England Biolabs, and OriGene Technologies. Show Less Read more